The Enterprise Value as of October 2024 (TTM) for CTI BioPharma Corp. (CTIC) is 1.22B

According to CTI BioPharma Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.22B. This represents a change of 79.71% compared to the average of 681.17M of the last 4 quarters.

CTI BioPharma Corp. (CTIC) Historical Enterprise Value (quarterly & annually)

How has CTIC Enterprise Value performed in the past?

The mean historical Enterprise Value of CTI BioPharma Corp. over the last ten years is 210.67M. The current 1.22B Enterprise Value has changed 58.01% with respect to the historical average. Over the past ten years (40 quarters), CTIC's Enterprise Value was at its highest in in the December 2022 quarter at 791.38M. The Enterprise Value was at its lowest in in the March 2020 quarter at -13140880.00.

CTI BioPharma Corp. (CTIC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CTI BioPharma Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CTI BioPharma Corp. (CTIC) Average Enterprise Value

How has CTIC Enterprise Value performed in the past?

The current Enterprise Value of CTI BioPharma Corp. (CTIC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CTI BioPharma Corp. (CTIC) Enterprise Value vs. Peers

How is CTIC’s Enterprise Value compared to its peers?

CTI BioPharma Corp.’s Enterprise Value is greater than Rigel Pharmaceuticals, Inc. (290.67M), greater than Fortress Biotech, Inc. (62.11M), greater than Reviva Pharmaceuticals Holdings, Inc. (37.61M), greater than Ocuphire Pharma, Inc. (-8137032.00), greater than Protalix BioTherapeutics, Inc. (82.91M), greater than Seres Therapeutics, Inc. (284.89M), greater than Cidara Therapeutics, Inc. (-81592624.00), less than ImmunityBio, Inc. (3.26B), greater than Galera Therapeutics, Inc. (-5801938.00), greater than Selecta Biosciences, Inc. (69.24M), greater than Paratek Pharmaceuticals, Inc. (344.90M), greater than Corvus Pharmaceuticals, Inc. (436.85M), greater than Immutep Limited (292.59M), greater than Icosavax, Inc. (713.87M), greater than Verastem, Inc. (65.54M), less than ImmunoGen, Inc. (8.19B), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than Elevation Oncology, Inc. (4.05M), less than Viking Therapeutics, Inc. (7.12B), less than TG Therapeutics, Inc. (3.74B), greater than X4 Pharmaceuticals, Inc. (14.70M), greater than PDS Biotechnology Corporation (80.79M), less than Madrigal Pharmaceuticals, Inc. (4.19B),

Build a custom stock screener for CTI BioPharma Corp. (CTIC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CTI BioPharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CTI BioPharma Corp. (CTIC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CTI BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.